You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 2020124017
Dec 20201203
Jan 20211703
Feb 20211202
Mar 202148010
Apr 20213006
May 202118010
Jun 2021105
Jul 2021006
Aug 2021005
Sep 20210014
Oct 202114027
Nov 202128018
Dec 20212204
Jan 20221202
Feb 20221404
Mar 20222601
Apr 20223203
May 20221805
Jun 20223606
Jul 20222205
Aug 202234013
Sep 20225608
Oct 20222006
Nov 20221606
Dec 20221400
Jan 20234006
Feb 20232603
Mar 20231401
Apr 2023804
May 20231201
Jun 20231002
Jul 20231204
Aug 2023603
Sep 20231401
Oct 20232203
Nov 20233203
Dec 20234402
Jan 2024603
Feb 20243202
Mar 20242007
Apr 20246021
May 20242802
Jun 20244402
Jul 20242402
Aug 20242604
Sep 20241202
Oct 202420010
Nov 20242605
Total11100282